An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to message these accounts privately for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
However, physicians and chemists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in users administering products of uncertain source.
Some professionals stated the demand for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.
Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and customer laws, risking fines, prosecution or imprisonment.
Platform Reaction and Content Removal
According to the social media company, the platform has taken down violative content and prohibited related keywords and search suggestions. The organization said it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.
Online Marketplace Operations
Investigations also found groups with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.
After moments of entering one group, a seller shared contact information, where most purchases take place. The vendor provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.
Item Information and Pricing
Within these communities, messages show black plastic parcels with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for the messaging service stated it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering substances they cannot confirm. Although the science behind this drug is valid, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.
Her staff has previously seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to potentially significant medical dangers”.
